Clinical Trials Browser

FED × pembrolizumab × 90 days × Clear all

NCT04104893 2026-02-27

CHOMP

Phase 2 Active not recruiting

Turcot syndrome, Prostatic Neoplasms

NCT05467748 2026-01-27

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms